TIDMEVOL TIDM3D.P 
 
RNS Number : 1295V 
Evolve Capital PLC 
28 October 2010 
 

                                                                 28 October 2010 
                               Evolve Capital plc 
                          ("Evolve" or the "Company") 
 
            Proposed Admission of Investee Company to trading on AIM 
 
The Board of Evolve are pleased to note yesterday's announcement by 3D 
Diagnostic Imaging plc ("3D"), a PLUS-quoted company in which Evolve has a 
substantial investment, that it has conditionally raised GBP2.71 million (before 
expenses) by way of a placing of 45,248,318 shares at a price of 6p per share 
and that it intends to move from PLUS-quoted onto AIM. 
 
It is expected that 3D's admission onto AIM ("Admission") will become effective 
and dealings in its enlarged share capital will commence on 22 November 2010. 
The market capitalisation of 3D, based upon the placing price of 6p per share, 
will be GBP10.23 million. The closing mid-market price of 3D on 27 October 2010 
was 10p per share. Following Admission Evolve will hold 53,974,354 ordinary 
shares in 3D equivalent to 31.66% of its enlarged issued share capital. 
 
A copy of 3D's admission document is available at the offices of 3D's lawyers, 
Marriott Harrison, and further information on the company is available at 
www.3ddiagnosticimaging.com. 
 
Oliver Vaughan, Evolve's Chairman, commented: 
 
"The Board believe that 3D is an excellent example of Evolve's wider business 
model. We have supported the company from the outset and are delighted with the 
progress that it has made to date. We look forward to further exciting 
developments in the future." 
 
 
For further information please contact: 
 
+---------------------------------------------+----------------------+ 
| Evolve Capital plc                          |                      | 
| Oliver Vaughan, Chairman                    | Tel: 020 7937 4445   | 
|                                             |                      | 
+---------------------------------------------+----------------------+ 
| Allenby Capital Limited                     |                      | 
| Nick Naylor                                 | Tel: 020 3328 5656   | 
| Nick Athanas                                |                      | 
+---------------------------------------------+----------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCFEWFWWFSSESS
Evolve Capital (LSE:EVOL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Evolve Capital Charts.
Evolve Capital (LSE:EVOL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Evolve Capital Charts.